tradingkey.logo

Cibus Inc

CBUS
查看详细走势图
1.710USD
+0.170+11.04%
收盘 12/19, 16:00美东报价延迟15分钟
89.89M总市值
亏损市盈率 TTM

Cibus Inc

1.710
+0.170+11.04%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+11.04%

5天

+6.21%

1月

+35.71%

6月

+14.00%

今年开始到现在

-38.49%

1年

-35.35%

查看详细走势图

TradingKey Cibus Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Cibus Inc当前公司基本面数据相对稳定,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名140/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价14.40。中期看,股价处于上升通道。近一个月,市场表现很强,但基本面和技术面综合得分较低,很强的走势没有得到基本面和技术面印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Cibus Inc评分

相关信息

行业排名
140 / 208
全市场排名
353 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
14.400
目标均价
+805.66%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Cibus Inc亮点

亮点风险
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
业绩高增长
公司营业收入稳步增长,连续3年增长2614.65%
业绩增长期
公司处于发展阶段,最新年度总收入4.26M美元
利润高增长
公司净利润处于行业前列,最新年度总收入4.26M美元
估值合理
公司最新PE估值-0.63,处于3年历史合理位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值962.37K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.12

Cibus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Cibus Inc简介

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
公司代码CBUS
公司Cibus Inc
CEOBeetham (Peter Ronald)
网址https://www.cibus.com/

常见问题

Cibus Inc(CBUS)的当前股价是多少?

Cibus Inc(CBUS)的当前股价是 1.710。

Cibus Inc的股票代码是什么?

Cibus Inc的股票代码是CBUS。

Cibus Inc股票的52周最高点是多少?

Cibus Inc股票的52周最高点是3.500。

Cibus Inc股票的52周最低点是多少?

Cibus Inc股票的52周最低点是1.090。

Cibus Inc的市值是多少?

Cibus Inc的市值是89.89M。

Cibus Inc的净利润是多少?

Cibus Inc的净利润为-251.39M。

现在Cibus Inc(CBUS)的股票是买入、持有还是卖出?

根据分析师评级,Cibus Inc(CBUS)的总体评级为买入,目标价格为14.400。

Cibus Inc(CBUS)股票的每股收益(EPS TTM)是多少

Cibus Inc(CBUS)股票的每股收益(EPS TTM)是-2.713。
KeyAI